Pharmaceutical Benefits Scheme becoming unsustainable, says Senate committee

Australia has the highest incidence of cancer in the world, and the committee has been examining how to keep drugs affordable and available to patients

Related: Leaked trade deal terms prompt fears for Pharmaceutical Benefits Scheme

A Senate committee has called on the government to undertake a comprehensive review of its system for subsidising medicines to taxpayers, as the increasing number of new and expensive drugs being listed on the Pharmaceutical Benefits Scheme is becoming unsustainable.